Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-23-016054

Head of R&D, CSO gave up 522 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Rodino-Klapac Louise · Head of R&D, CSO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-01 Shares withheld for taxes : show line 1 in the form −522 $147.57 $77,032 67,716 D
Loading xslF345X03/doc4.xml…